Pain Management Testing in the Opioid Crisis and Beyond

By MCL Education • July 22, 2020

Expires July 22, 2022

Presentation

Video length: 41 minutes

In this month’s “Virtual Lecture,” Christine Snozek, Ph.D., discusses the opioid epidemic as it relates to pain management along with what changes have been made regarding regulations and laboratory support.

Objectives

Upon completion of this program, participants should be able to:

  • Describe current trends in pain management in response to the ongoing opioid epidemic.
  • Explain how laboratory testing can support pain management practices.
  • Identify implications for patient care when laboratory tests are not used appropriately or interpreted correctly.

Intended Audience

This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.

Faculty

Christine Snozek, Ph.D.
Associate Professor of Laboratory Medicine and Pathology
Department of Laboratory Medicine and Pathology
Mayo Clinic, Scottsdale, Arizona

Credit

The following types of credit are offered for this program:

ASCLS P.A.C.E.®

To obtain credit:

  1. Watch the video.
  2. Complete the posttest and evaluation that launches immediately following the video.
  3. Generate and print your certificate(s).

Level of instruction for this program is basic.

ASCLS P.A.C.E.®

Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 0.5 P.A.C.E.® contact hour.

Faculty Disclosure

Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.

Questions?

Contact us: mcleducation@mayo.edu

MCL Education (@mmledu)

MCL Education

This post was developed by our Education and Technical Publications Team.

Related Posts
New pharmacogenetics program helps St. Clair Health improve patient care
Mayo Clinic Laboratories named by HHS to expand monkeypox testing capacity
The Lab’s Role in Health and Equity